Clinical Trials on Leukemia, Myelomonocytic, Chronic in New Zealand
Total 4905 results
-
CelgeneCompletedLymphoma | Acute Myeloid Leukemia | Myelodysplastic Syndromes | Multiple Myeloma | Leukemia, Myelomonocytic, ChronicUnited States
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyCompletedAcute Myeloid LeukaemiaFrance, United States, Australia
-
Bristol-Myers SquibbCompletedChronic Lymphocytic LeukemiaUnited States
-
Aptevo TherapeuticsCompletedChronic Lymphocytic Leukemia (CLL)United States, Austria, Germany, Poland, Spain
-
Celgene CorporationCompletedLeukemia Lymphocytic Chronic B-CellUnited States, Germany
-
Gilead SciencesTerminatedChronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL)United States
-
TakedaActive, not recruitingMyeloid Leukemia, Chronic, Chronic PhaseUnited States, Spain, Taiwan, Australia, Canada, Russian Federation, Sweden, Switzerland, Germany, United Kingdom, Poland, Korea, Republic of, Argentina, Hong Kong, Singapore, Italy, Chile, Czechia, Denmark, France, Portugal
-
Gilead SciencesCompletedChronic Hepatitis BUnited States, New Zealand
-
Genentech, Inc.CompletedLymphocytic Leukemia, ChronicUnited States
-
Astex Pharmaceuticals, Inc.CompletedChronic Myelogenous LeukemiaUnited States, Canada
-
University of RochesterCompleted
-
Precision BioSciences, Inc.CompletedLymphoma, Non-Hodgkin | Chronic Lymphocytic Leukemia | B-cell Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | B-cell Non Hodgkin Lymphoma | Leukemia, Lymphocytic, Chronic | Non-Hodgkin's Lymphoma, Relapsed | Non-Hodgkin's Lymphoma Refractory | Chronic Lymphoid Leukemia in RelapseUnited States
-
GlaxoSmithKlineTerminatedLeukaemia, Myelocytic, AcuteUnited States, Australia, Canada
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)Completed
-
Seagen Inc.Genentech, Inc.CompletedLeukemia, Lymphocytic, ChronicUnited States
-
Genentech, Inc.CompletedChronic Lymphocytic LeukemiaUnited States
-
NovartisNational Cancer Institute (NCI)Completed
-
Fisher and Paykel HealthcareMedical Research Institute of New Zealand; Alana HealthcareTerminatedChronic Obstructive Pulmonary Disease | COPDUnited States, New Zealand
-
Astex Pharmaceuticals, Inc.RecruitingAcute Myeloid Leukemia | Myelodysplastic Syndromes | Chronic Myelocytic Leukemia | Myelodysplastic Syndrome/NeoplasmUnited States
-
Genentech, Inc.AbbVie (prior sponsor, Abbott)CompletedLymphocytic Leukemia, ChronicUnited States, United Kingdom
-
Memorial Sloan Kettering Cancer CenterAstraZeneca; Genentech, Inc.Active, not recruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
Astex Pharmaceuticals, Inc.Eisai Inc.CompletedChronic Myelogenous LeukemiaUnited States, Canada
-
SanofiTerminatedAcute Myeloid LeukaemiaUnited States
-
Georgetown UniversityHackensack Meridian HealthActive, not recruitingChronic Lymphocytic LeukemiaUnited States
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)CompletedLymphoma | LeukemiaUnited States
-
New York Medical CollegeUnknownAcute Lymphoblastic Leukemia | Lymphoblastic Lymphoma | Chronic Myelogenous Leukemia | Burkitts Leukemia/LymphomaUnited States
-
Acerta Pharma BVActive, not recruitingChronic Lymphocytic LeukemiaUnited States, Italy, Spain, United Kingdom, Belgium, Denmark, Hungary, Poland, Australia, Germany, Israel, Netherlands, Turkey, France, New Zealand
-
AbbVieGenentech, Inc.CompletedChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States, Australia
-
Genzyme, a Sanofi CompanyCompletedLeukemia, Lymphocytic, Chronic, B-CellUnited States
-
Arrow TherapeuticsDDS, Dundee; David Mutimer, Birmingham; Ed Gane, ACS New ZealandTerminatedChronic Hepatitis CNew Zealand, United Kingdom
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedSecondary Acute Myeloid Leukemia | Childhood Acute Erythroleukemia (M6) | Childhood Acute Megakaryocytic Leukemia (M7) | Childhood Acute Monoblastic Leukemia (M5a) | Childhood Acute Monocytic Leukemia (M5b) | Childhood Acute Myeloblastic Leukemia With Maturation (M2) | Childhood Acute Myeloblastic... and other conditionsUnited States, Canada, Australia, Puerto Rico
-
Astellas Pharma IncOSI Pharmaceuticals; Cell PathwaysCompletedChronic Lymphocytic LeukemiaUnited States
-
AbbVieGenentech, Inc.CompletedChronic Lymphocytic LeukemiaUnited States, Australia, Germany, United Kingdom
-
Chronic Lymphocytic Leukemia Research ConsortiumCelgene CorporationUnknownChronic Lymphocytic Leukemia | CLL | Untreated | First-Line | Front-line | Initial TherapyUnited States
-
Pharmacyclics LLC.CompletedB-cell Chronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
Alexion PharmaceuticalsTerminatedMultiple Myeloma | B-cell Chronic Lymphocytic LeukemiaUnited States
-
National Cancer Institute (NCI)Active, not recruitingStage I Chronic Lymphocytic Leukemia | Stage II Chronic Lymphocytic Leukemia | Stage III Chronic Lymphocytic Leukemia | Stage IV Chronic Lymphocytic LeukemiaUnited States, Canada
-
Acerta Pharma BVActive, not recruitingChronic Lymphocytic Leukemia | Prolymphocytic Leukemia | Small Lymphocytic Lymphoma | Richter's SyndromeUnited States, United Kingdom, Italy
-
PfizerCompletedLeukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) PositiveFrance, United States, Canada, Spain, Czechia, Singapore, Thailand, Denmark, Norway, Korea, Republic of, Finland, Hungary, Sweden, Netherlands, Italy, Germany, Ukraine, South Africa, Taiwan, Australia, Belgium, Israel, Mexico, Poland, S... and more
-
Novartis PharmaceuticalsTerminatedChronic Myelogenous Leukemia - Chronic PhaseUnited States
-
BioCryst PharmaceuticalsCompletedChronic Lymphocytic Leukemia (CLL)United States, Australia
-
Marlise Luskin, MDNovartisRecruitingB-cell Acute Lymphoblastic Leukemia | Chronic Myeloid Leukemia (CML) in Lymphoid Blast Crisis | Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Ph+ ALLUnited States
-
National Cancer Institute (NCI)Eastern Cooperative Oncology Group; NCIC Clinical Trials Group; SWOG Cancer Research...CompletedStage I Chronic Lymphocytic Leukemia | Stage II Chronic Lymphocytic Leukemia | Stage III Chronic Lymphocytic Leukemia | Stage IV Chronic Lymphocytic LeukemiaUnited States, Canada
-
TG Therapeutics, Inc.James P. Wilmot Cancer CenterTerminatedChronic Lymphocytic Leukemia | Non-Hodgkin LymphomaUnited States
-
Zhejiang DTRM BiopharmaRecruitingFollicular Lymphoma | Diffuse Large B Cell Lymphoma | Refractory Chronic Lymphocytic Leukemia | Richter's Transformation | Relapsed Chronic Lymphocytic LeukemiaUnited States
-
Fisher and Paykel HealthcareRecruiting
-
WiSP Wissenschaftlicher Service Pharma GmbHMundipharma Research GmbH & Co KG; Klinikum Leverkusen gGmbH; ribosepharm GmbHCompletedChronic Lymphocytic LeukemiaGermany
-
GlaxoSmithKlineNational Cancer Institute (NCI)Completed
-
Weill Medical College of Cornell UniversityGenentech, Inc.; BeiGeneRecruitingLeukemia, Lymphocytic, Chronic, B-CellUnited States
-
Pharmacyclics LLC.Janssen Research & Development, LLCCompletedRelapsed or Refractory Chronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States, Australia, Austria, Belgium, France, Ireland, Italy, Poland, Spain, United Kingdom